Incontinentia pigmenti: treatment of IP with topical tacrolimus.
Incontinentia pigmenti (IP), or Bloch-Sulzberger syndrome, is a rare X-linked dominant genodermatosis primarily affecting females. Although IP affects many organ systems, the hallmark feature of this disease is its characteristic cutaneous eruption along the lines of Blaschko that evolves through four distinct stages: inflammatory/vesiculobullous, verrucous, hyperpigmented and hypopigmented/ atrophic. We describe a case of IP in its vesicular stage that completely resolved with topical Protopic (tacrolimus) 0.1% ointment. The treatment successfully halted the progression of disease through its subsequent disfiguring stages.
Department of Pathology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA 02215, USA. cjessup@bidmc.harvard.edu
Chad J
CJ
Jessup
Shane C
SC
Morgan
Lisa M
LM
Cohen
Daniel E
DE
Viders
D000279:Administration, Cutaneous; D018450:Disease Progression; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007184:Incontinentia Pigmenti / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D007231:Infant, Newborn; D009824:Ointments; D016559:Tacrolimus / Q000008:administration & dosage / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D009824:Ointments; D016559:Tacrolimus